Genisphere Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 7

Genisphere General Information

Description

Operator of a targeted drug delivery platform company focused on nanotechnology. The company specializes in a DNA-based targeted drug delivery platform that is engineered and cross-linked to form a stable architecture while maintaining the biocompatibility of the nucleic acid building blocks and demonstrating efficacy and safety with a variety of drugs cargo across multiple indications.

Contact Information

Website
www.genisphere.com
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 2801 Sterling Drive
  • Hatfield, PA 19440
  • United States
+1 (215)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • 2801 Sterling Drive
  • Hatfield, PA 19440
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genisphere Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genisphere‘s full profile, request access.

Request a free trial

Genisphere Patents

  • 123

    Total Documents Applications and Grants

  • Total Patents Families

  • 44

    Granted

  • Pending

  • Expiring in next 12 mo

Genisphere Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021091899-A1 Brain-specific angiogenesis inhibitor 1 (bai1) antibodies and uses thereof Inactive 04-Nov-2019
AU-2017221437-A1 Nucleic acid carriers and therapeutic methods of use Inactive 19-Feb-2016
WO-2017143156-A1 Nucleic acid carriers and therapeutic methods of use Inactive 19-Feb-2016
WO-2017143171-A1 Nucleic acid carriers and therapeutic methods of use Inactive 19-Feb-2016
EP-3289084-A1 Sirna inhibition of human antigen r expression for treatment of cancer Active 17-Apr-2015 A61K47/551
To view Genisphere’s complete patent history, request access »

Genisphere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genisphere FAQs

  • When was Genisphere founded?

    Genisphere was founded in 1997.

  • Where is Genisphere headquartered?

    Genisphere is headquartered in Hatfield, PA.

  • What is the size of Genisphere?

    Genisphere has 10 total employees.

  • What industry is Genisphere in?

    Genisphere’s primary industry is Drug Delivery.

  • Is Genisphere a private or public company?

    Genisphere is a Private company.

  • What is Genisphere’s current revenue?

    The current revenue for Genisphere is .

  • How much funding has Genisphere raised over time?

    Genisphere has raised $14.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process